| |
|
|
|
Urovant Sciences Ltd.  
|
|
10.3 0.25 (0.02%) |
11-20 16:00 |
|
Open: |
9.83 |
Pre close: |
10.05 |
Target:
|
12.85 
|
|
High: |
10.445 |
Low: |
9.75 |
Resistance:
|
11.00
12.85
|
|
Volume: |
32,970 |
Market Cap: |
313M |
Support:
|
9.89
9.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.66
|
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
9.66 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
9.02 |
Stochastic Oscillator |
%K(14,3):
|
43.85 |
|
MA(250): |
8.87 |
%D(3): |
23.08 |
|
Average Volume(K) |
3-Month: |
6138
|
52-Week |
High:
|
14.49 |
|
10-Days: |
3931 |
Low: |
4.06 |
|
RSI |
RSI(14):
|
60.79 |
Change(%): |
28.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.620 |
Return on Equity (ttm) |
-1287.6 |
Shares Out. (M) |
30.38 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-136.9 |
Shares Float (M) |
5.61 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
74.87 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.81 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
756 |
|
Book Value (p.s.) |
0.780 |
EBITDA (p.s.) |
-3.538 |
P/E |
-2.85 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
13.21 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
